LNP-Based Therapies for Lasting Relief in Monogenic Liver Disorders

Time: 11:30 am
day: Day One


  • LNP and AAV: comparisons in immunogenicity and toxicity and potential for combinatorial approaches
  • An overview of immunogenicity and toxicity in metabolic liver disease, striving for enhanced targeting and uptake
  • Confronting the challenge of efficiently delivering therapeutic agents to liver cells using LNPs